Diabetes
-
4 diabetes tech execs on the future of multi-analyte glucose sensors
Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.
By Elise Reuter • June 22, 2026 -
In a first, Dexcom’s OTC glucose sensor is cleared for kids
The Stelo over-the-counter glucose monitor can now be used by children as young as two years.
By Elise Reuter • June 15, 2026 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Top medtech stories from ADA’s Scientific Sessions
Dexcom, Abbott, MiniMed and Insulet featured upcoming technologies at the American Diabetes Association’s annual event. Catch up on news coming out of the conference.
By Elise Reuter • June 12, 2026 -
Why Insulet thinks its fully closed loop system will stand apart from rivals
Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be “completely different” than those being developed by MiniMed and Tandem Diabetes Care.
By Elise Reuter • June 11, 2026 -
MiniMed is in the lead as diabetes tech firms focus on ‘fully closed loop’ systems, exec says
Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in developing automated insulin delivery systems that don’t require meal announcements.
By Elise Reuter • June 9, 2026 -
Dexcom bolsters evidence for glucose sensors for Type 2 diabetes
New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said.
By Elise Reuter • June 9, 2026 -
3 takeaways from ADA
Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.
By Elise Reuter • June 8, 2026 -
Dexcom buys Nutrisense; Insulet rolls out patch pump update
In the lead-up to the American Diabetes Association’s Scientific Sessions, Dexcom announced an acquisition and Insulet improved the software for its latest patch pump.
By Elise Reuter • June 5, 2026 -
Deep Dive
Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.
Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.
By Elise Reuter • June 4, 2026 -
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.
By Elise Reuter • June 3, 2026 -
Court overturns Insulet’s $59M trade secret verdict against EOFlow
The U.S. appeals court ruled that Insulet filed the lawsuit too late, considering when it should have learned of the trade secret concerns.
By Nick Paul Taylor • June 1, 2026 -
Abbott receives CE mark for dual glucose-ketone sensor
Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.
By Elise Reuter • May 27, 2026 -
Insulet recalls 7M patch pumps due to leak risk
The recall is Insulet’s second this year related to tears in the device tubing. So far, 24 serious adverse events have been reported.
By Elise Reuter • May 27, 2026 -
Dexcom warns of scrapped glucose sensors being resold
Dexcom has identified two lots of G7 sensors that have been stolen, sold and used by customers.
By Elise Reuter • Updated May 27, 2026 -
Beta Bionics to launch its first insulin patch pump to compete with Insulet
The device called Mint, which would work with the company’s adaptive insulin dosing algorithm, is expected to debut in the first half of 2027.
By Elise Reuter • May 26, 2026 -
Embecta closes Owen Mumford acquisition for up to $201M
Embecta bought the company, which has an auto-injector platform, to expand outside of diabetes care.
By Elise Reuter • May 18, 2026 -
Dexcom to add 2 board directors with activist investor Elliott
CEO Jake Leach also discussed the company’s plans for its G8 glucose sensor, dual-analyte sensing and Medicare coverage at an investor day.
By Elise Reuter • May 15, 2026 -
Tandem to file tubeless insulin pump with FDA this quarter
The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device.
By Elise Reuter • May 8, 2026 -
Insulet raises revenue expectations for 2026
CEO Ashley McEvoy also shared an update on the company’s recent recall of insulin patch pumps.
By Elise Reuter • May 6, 2026 -
Insulet starts study of closed loop insulin delivery system
Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.
By Elise Reuter • May 4, 2026 -
FDA advises users of Trividia glucometer to switch to alternatives
The potential for error code confusion to cause delayed or improper treatment led the FDA to recommend users transition to other blood glucose meters.
By Nick Paul Taylor • April 30, 2026 -
Tandem recalls Mobi insulin pumps over software malfunction
A malfunction may cause insulin delivery to stop. Tandem instructed users to update their pump software as soon as possible.
By Elise Reuter • April 22, 2026 -
MiniMed posts double-digit sales growth, widening net loss
New glucose sensors and a partnership with Abbott are expected to drive sales growth at MiniMed, BTIG analyst Marie Thibault wrote.
By Elise Reuter • April 21, 2026 -
Glucotrack plans US trial of implantable glucose monitor this year
Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the second half of 2026.
By Elise Reuter • March 27, 2026 -
Medtronic lowers earnings forecast after MiniMed IPO
The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.
By Elise Reuter • March 25, 2026